Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-10-01 | 2024-09-25 |
| Drug Identification Number | 02392763 | 02392763 |
| Brand name | TRANEXAMIC ACID INJECTION | TRANEXAMIC ACID INJECTION |
| Common or Proper name | TRANEXAMIC ACID INJECTION 100MG/ML | TRANEXAMIC ACID INJECTION 100MG/ML |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | TRANEXAMIC ACID | TRANEXAMIC ACID |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 x 5mL vial / fiole | 10 x 5mL vial / fiole |
| ATC code | B02AA | B02AA |
| ATC description | ANTIFIBRINOLYTICS | ANTIFIBRINOLYTICS |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | ||
| Actual start date | 2024-09-24 | 2024-09-24 |
| Estimated end date | 2024-10-25 | 2024-11-04 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | There is product available at CPDN Delta. The 10mL format available at Omega and CPDN can be used as a substitute. | There is product available at CPDN Delta. The 10mL format available at Omega and CPDN can be used as a substitute. |
| Health Canada comments |